ADPKD Treatment Guide: Slowing Progression, Managing Complications, Preserving Quality of Life

Autosomal Dominant Polycystic Kidney Disease (ADPKD) causes progressive cyst growth in the kidneys (and often the liver). Treatment focuses on slowing disease progression, managing complications, and maintaining quality of life through a multidisciplinary approach.

Core Management Pillars

1. Blood Pressure Control (Critical)

• Target <130/80 mmHg (per KDIGO guidelines).
• ACE inhibitors or ARBs are first-line—they’re renoprotective and may slow cyst growth.
• Early treatment, even with normal BP, may delay cyst expansion.

2. Diet and Hydration

• Sodium <2,300 mg/day (ideally <1,500 mg).
• High fluid intake: 2.5–3 L/day suppresses vasopressin, slowing cyst growth.
• Moderate protein: 0.8–1.0 g/kg/day; avoid excess.
• Caffeine: Evidence is mixed; moderate intake is likely fine.

3. Pain Management

• Acetaminophen first-line.
• Avoid chronic NSAIDs (nephrotoxic).
• Tricyclics or gabapentinoids for neuropathic components.
• Large, symptomatic cysts: aspiration/sclerotherapy.

4. Kidney Stone Prevention

• High fluid intake (as above).
• Thiazide diuretics reduce urinary calcium.
• Potassium citrate for hypocitraturia.
• Limit oxalate if hyperoxaluria is present.

5. Infection Management

• Cyst infections require prolonged lipophilic antibiotics (fluoroquinolones, TMP-SMX, metronidazole) that penetrate cysts.
• Recurrent infections may need cyst drainage or nephrectomy.

6. Liver Cyst Management

• Usually asymptomatic.
• If symptomatic: aspiration + sclerotherapy, fenestration, or partial hepatectomy.
• Avoid estrogen (OCPs, HRT)—may stimulate growth.

7. Tolvaptan (Jynarque)

• Vasopressin V2 receptor antagonist; slows cyst growth and eGFR decline.
• Indicated for rapidly progressing ADPKD (based on age, kidney volume, eGFR).
• Requires REMS monitoring for liver injury (monthly LFTs).
• Causes aquaresis → high fluid intake is essential.

8. Advanced Disease

• Dialysis (hemodialysis or peritoneal) when eGFR <15 or uremic symptoms appear.
• Kidney transplantation: excellent outcomes; preemptive transplant is ideal.

Lifestyle and Monitoring

• Regular aerobic exercise; avoid contact sports (cyst rupture risk).
• Annual eGFR, urine albumin, blood pressure.
• Periodic MRI/CT for total kidney volume (TKV) if on tolvaptan or in a trial.
• Genetic counseling for family members.

Multidisciplinary care—nephrology, genetics, pain management, nutrition, transplant—optimizes outcomes.